Polymeric implants for cancer chemotherapy

Advanced Drug Delivery Reviews

Volumn 26, Issue 2-3, 1997, Pages 209-230

  Fung, Lawrence K ^a   Saltzman, W Mark ^a  

^a Cornell University   (United States)

Author keywords

Biodegradable polymers; Chemotherapeutic agnets; Intratumoral delivery; Local delivery; Microspheres; Polymer pellets; Polymeric chemotherapy; Polymers; Sustained deliver6

Indexed keywords

BIODEGRADATION; CONTROLLED DRUG DELIVERY; ONCOLOGY; POLYMERS;

MICROSPHERES;

IMPLANTS (SURGICAL);

ANTIINFECTIVE AGENT; CARMUSTINE; GOSERELIN; LEUPRORELIN; MICROSPHERE; POLYMER; TRIPTORELIN;

ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; HUMAN; IMPLANT; PRIORITY JOURNAL; REVIEW;

EID: 0031558233     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00036-7     Document Type: Review

References (147)

1. W.B. Pratt, R.W. Ruddon, W.D. Ensminger, J. Maybaum, The Anticancer Drugs. 2nd ed. Oxford University Press, New York, 1994.
2. P.M. Black, Brain tumors (first of two parts), New Engl. J. Med. 324 (1991) 1471-1476.
3. N. Kemeny, D. Civalleri, P. Edman, B. Nilsson, K. Gunnarsson, K. Hakansson, T. Taguchi, K.R. Aiger, Liver cancer: a review of current treatment options, in: N. Kemeny (Ed.), An update of regional treatment of liver cancer. The role of vascular occlusion, Wells Medical: Kent, England, 1992, pp. 7-16.
4. R.K. Jain, Vascular and interstitial barriers to delivery of therapeutic agents in tumors, Cancer Metastasis Rev. 9 (1990) 253-266.
5. P. Calabresi, B.A. Chabner, XII, in: A. Goodman-Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.), Chemotherapy of neoplastic diseases. The Pharmacological Basis of Therapeutics, New York, NY: Pergamon Press, 1990, pp. 1202-1263.
6. H. Maeda, SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer therapy, Adv. Drug Deliv. Rev. 6 (1991) 181-202.
7. R. Duncan, Drug-polymer conjugates: potential for improved chemotherapy, Anti-Cancer Drugs 3 (1992) 175-210.
8. A. Olivi, H. Brem, Interstitial chemotherapy with sustained-release polymer systems for the treatment of malignant gliomas, Recent Results Cancer Res. 135 (1994) 149-154.
9. T. Tomita, Interstitial chemotherapy for brain tumors: review, J. Neuro-Oncol. 10 (1991) 57-74.
10. K.A. Walter, R.J. Tamargo, A. Olivi, P.C. Burger, H. Brem, Intratumoral chemotherapy, Neurosurgery 37 (1995) 1129-1145.
11. M. Mak, L. Fung, J.F. Strasser, W.M. Saltzman, Distribution of drugs following controlled delivery to the brain interstitium, J. Neuro-Oncol. 26 (1995) 91-102.
12. H. Brem, R. Langer, Polymer based drug delivery to the brain, Scientific American: Science and Medicine 3(4) (1996) 2-11.
13. W.R. Gombotz, D.K. Pettit, Biodegradable polymers for protein and peptide drug delivery, Bioconjugate Chem. 6 (1995) 332-351.
14. H. Okada, H. Toguchi, Biodegradable microspheres in drug delivery, Critical Reviews in Therapeutic Drug Carrier Systems 12(1) (1995) 1-99.
15. T.L. Whateley, Biodegradable microspheres for controlled drug delivery, in: D.R. Karsa and R.A. Stephenson (Eds.), Encapsulation and Controlled Release, Royal Society of Chemistry: Cambridge, 1993.
16. T. Taguchi, Chemo-occulsion for the treatment of liver cancer: a new technique using degradable starch microspheres, Clinical Pharmacokinetics 26(4) (1994) 275-291.
17. R. Langer, New methods of drug delivery, Science 249 (1990) 1527-1533.
18. T.L. Wyatt, W.M. Saltzman, Protein delivery from non-degradable polymer matrices, in: L. Sanders (Ed.), Protein Delivery - Physical Systems, Plenum Press, New York, NY, 1997, pp. 119-137.
19. W.M. Saltzman, Antibodies for treating and preventing disease: the potential role of polymeric controlled release, Crit. Rev. Ther. Drug Carrier Syst. 10 (1993) 111-142.
20. P.Y.P. Kuo, W.M. Saltzman, Novel systems for controlled delivery of macromolecules, Crit. Rev. Eukaryotic Gene Expr. 6 (1996) 59-73.
21. J. Folkman, D. Long, The use of silicone rubber as a carrier for prolonged drug therapy, J. Surg. Res. 4 (1964) 139-142.
22. J. Folkman, D.M. Long, R. Rosenbaum, Silicone rubber: a new diffusion property useful for general anesthesia, Science 154 (1966) 148-149.
23. N. Ueno, M.F. Rofojo, L.H.S. Liu, Controlled release rate of a lipophilic drug (BCNU) from a refillable silicone rubber device, J. Biomed. Mater. Res. 16 (1982) 669-677.
24. M.B. Yang, R.J. Tamargo, H. Brem, Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer, Cancer Res. 49 (1989) 5103-5107.
25. S.W. Kim, Y.H. Bae, T. Okano, Hydrogels: swelling, drug loading, and release [Review], Pharm. Res. 9 (1992) 283-290.
26. P.D. Craig, J.A. Williams, K.W. Davis, A.D. Magoun, A.J. Levy, S. Bogdansky, J.P. Jones Jr., A biologic comparison of polyglactin 910 and polyglycolic acid synthetic absorbable sutures, Surg. Gynecol. Obstet. 141 (1975) 1-10.
27. D.E. Cutright, J.D. Beauley, B. Perez, Histologic comparison of polylactic and polyglycolic acid sutures, Oral Surg. 32 (1971) 165-173.
28. L.K. Fung, Theoretical and experimental pharmacokinetics of polymer delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a rat brain model. In: Chemical Engineering. The Johns Hopkins University, Baltimore, 1996.
29. M.P. Wu, J.A. Tamada, H. Brem, R. Langer, In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy, Journal of Biomedical Materials Research 28 (1994) 387-395.
30. R. Jain, Barriers to drug delivery in solid tumors, Scientific American 271 (1994) 58-65.
31. V.C. Jordan, Hormones, in: S.B. Kahn, R.R. Love, C. Sherman, R. Chakravorty (Eds.), Concepts in Cancer Medicine, Grune and Stratton, Inc.: New York, NY, 1983, pp. 177-185.
32. T.W. Redding, A.V. Schally, Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone, Proceedings for the National Academy of Science of the United States of America 78 (1981) 6509-6512.
33. N. Faure, F. Labrie, A. Lemay, A. Belanger, Y. Gourdeau, B. Laroche, G. Robert, Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men, Fertility and Sterility 37 (1982) 416-424.
34. The Leuprolide Study Group, Leuprolide versus diethylstilbestrol for metastatic prostate cancer. New England Journal of Medicine, 311 (1984) 1281-1286.
35. L.T. Sennello, R.A. Finley, S. Chu, C. Jagst, D. Max, D.E. Rollins, K.G. Tolman, Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration, Journal of Pharmaceutical Sciences 75 (1986) 158-160.
36. H. Okada, T. Heya, Y. Ogawa, H. Toguchi, T. Shimamoto, Sustained pharmacological activities in rats following single and repeated administration of once-a-month injectable microspheres of leuprolide acetate, Pharmaceutical Research 8 (1991) 584-587.
37. H. Okada, Y. Inoue, T. Heya, H. Ueno, T. Ogawa, H. Toguchi, Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate, Pharmaceutical Research 8 (1991) 787-791.
38. B.J.A. Furr, F.G. Hutchison, A biodegradable delivery system for peptides: preclinical experience with the gonado-tropin-releasing hormone agonist Zoladex®, J. Control. Release 21 (1992) 117-128.
39. R. Sharifi, M. Soloway, The Leuprolide Study Group, Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer, J. Urol. 143 (1990) 68-71.
40. H. Okada, Y. Doken, Y. Ogawa, H. Toguchi, Sustained suppression of the pituitary-gonadal axis by leuprorelin three-month depot microspheres in rats and dogs, Pharm. Res. 11 (1994) 1199-1203.
41. D.G. Haller, J.H. Glick, Progestational agents in advanced breast cancer: an overview, Semin. Oncol. 13 (1986) 2-8.
42. S. Li, M. Lepage, Y. Merand, A. Belanger, F. Labrie, Growth inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by controlled-release low-dose medroxyprogesterone acetate, Breast Cancer Res. Treat. 24 (1992) 127-137.
43. F. Labrie, S. Li, A. Belanger, J. Cote, Y. Merand, M. Lepage, Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a)anthracene in the rat, Breast Cancer Res. Treat. 26 (1993) 253-265.
44. S.L. Robbins, M. Angell, V. Kumar, Basic Pathology. 3rd ed. W.B. Saunders, Philadelphia, 1981.
45. F.H. Hochberg, A. Pruitt, Assumptions in the radiotherapy of glioblastoma, Neurology 30 (1980) 907-911.
46. R.J. Tamargo, J.I. Epstein, C.S. Reinhard, M. Chasin, H. Brem, Brain biocompatibility of a biodegradable, controlled-release polymer in rats, J. Biomed. Mater. Res. 23 (1989) 253-266.
47. H. Brem, A. Kader, J.I. Epstein, R.J. Tamargo, A. Domb, R. Langer, K.W. Leong, Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain, Selective Cancer Therapeutics 5 (1989) 55-65.
48. H. Brem, R.J. Tamargo, A. Olivi, M. Pinn, J.D. Weingart, M. Wharam, J.I. Epstein, Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain, J. Neurosurg. 80 (1994) 283-290.
49. R.J. Tamargo, J.S. Myseros, J.I. Epstein, M.B. Yang, M. Chasin, H. Brem, Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain, Cancer Res. 53 (1993) 329-333.
50. K.G. Buahin, H. Brem, Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release, J. Neuro-Oncol. 26 (1995) 103-110.
51. E.P. Sipos, B. Tyler, S. Piantadosi, P.C. Burger, H. Brem, Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors, Cancer Chemotherapy and Pharmacology 39 (1997) 383-389.
52. S.A. Grossman, C. Reinhard, M. Colvin, M. Chasin, R. Brundrett, R.J. Tamargo, H. Brem, The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers, J. Neurosurg. 76 (1992) 640-647.
53. L.K. Fung, M. Shin, B. Tyler, H. Brem, W.M. Saltzman, Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain, Pharm. Res. 13 (1996) 671-682.
54. L.K. Fung, M. Ewend, A. Sills, E. Sipos, R. Thompson, M. Watts, H. Brem, W.M. Saltzman, Carmustine distribution following Gliadel® polymer implantation and interstitial release in the primate brain. Abstract in conference proceedings from 1st Scientific Meeting for the Society of Neuro-Oncology. Santa Fe, New Mexico, 1996.
55. H. Brem, S.M. Mahaley Jr., N.A. Vick, K.L. Black, S.C. Schold Jr., P.C. Burger, A.H. Friedman, I.S. Ciric, T.W. Eller, J.W. Cozzens, J.N. Kenealy, Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas, J. Neurosurg. 74 (1991) 441-446.
56. H. Brem, S. Piantadosi, P.C. Burger, M. Walker, R. Selker, N.A. Vick, K. Black, M. Sisti, S. Brem, G. Mohr, P. Muller, R. Morawetz, S.C. Schold, Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas, Lancet 345 (1995) 1008-1012.
57. H. Brem, M.G. Ewend, S. Piantadosi, J. Greenhoot, P.C. Burger, M. Sisti, The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas - phase I trial, J. Neuro-Oncol. 26 (1995) 111-123.
58. A. Domb, S. Bogdansky, A. Olivi, K. Judy, C. Dureza, M.L. Pinn, M. Colvin, H. Brem, Controlled release of water soluble and hydrolytically unstable anticancer drugs from polymeric implants, Polymer Preprints 32 (1991) 219-220.
59. K.D. Judy, A. Olivi, K.G. Buahin, A. Domb, J.I. Epstein, O.M. Colvin, H. Brem, Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas, J. Neurosurg. 82 (1995) 481-486.
60. K.A. Walter, M.A. Cahan, A. Gur, B. Tyler, J. Hilton, M.O. Colvin, P.C. Burger, A. Domb, H. Brem, Interstitial taxol delivery from a biodegradable polymer implant against malignant glioma, Cancer Res. 54 (1994) 2207-2212.
61. J.D. Weingart, R.C. Thompson, B. Tyler, O.M. Colvin, H. Brem, Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model, Int. J. Cancer 62 (1995) 605-609.
62. J.D. Weingart, E.P. Sipos, H. Brem, The role of minocycline in the treatment of intracranial 9L glioma, J. Neurosurg. 82 (1995) 635-640.
63. R.J. Tamargo, K.W. Leong, H. Brem, Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate, J. Neuro-Oncol. 9 (1990) 131-138.
64. R. Yamashita, Experimental study of an anticancer drug delivery system using polylactic acid [Japanese], J. Jpn. Surg. Soc. 88 (1987) 401-412.
65. S.Y. Lin, L.F. Cheng, W.Y. Lui, C.F. Chen, S.H. Han, Tumoricidal effect of controlled-release polymeric needle devices containing adriamycin HCl in tumor-bearing mice, Biomater., Artif. Cells Artif. Organs 17 (1989) 189-203.
66. T. Kumanohoso, S. Natsugoe, M. Shimada, T. Aikou, K. Nakamura, K. Yamada, H. Fukuzaki, In vivo activity of bleomycin incorporated with biodegradable poly-DL-lactic acid and implanted in the mediastinum of dogs, J. Surg. Oncol. 57 (1994) 178-182.
67. A.H. Shikani, D.W. Eisele, A.J. Domb, Polymer delivery of chemotherapy for squamous cell carcinoma of the head and neck, Arch. Otolaryngol. Head Neck Surg. 120 (1994) 1242-1247.
68. S. Miura, Y. Mii, Y. Miyauchi, H. Ohgushi, T. Morishita, K. Hohnoki, M. Aoki, S. Tamai, Y. Konishi, Efficacy of slow-releasing anticancer drug delivery systems on transplantable osteosarcomas in rats, Jpn. J. Clin. Oncol. 25 (1995) 61-71.
69. V.T.J. Devita, S. Hellman, S.A. Rosenberg, Cancer Principles and Practice of Oncology. 4th ed. Vol. 2. J.B. Lippincott, Philadelphia, 1993.
70. L.E. Gerlowski, R. Jain, Physiologically based pharmacological modeling: principles and applications [Review], J. Pharm. Sci. 72 (1983) 1103-1127.
71. J.D. Fenstermacher, C.S. Patlak, R.G. Blasberg, Transport of material between brain extracellular fluid, brain cells and blood, Fed. Proc. 33 (1974) 2070-2074.
72. J.D. Fenstermacher, C.S. Patlak, The movements of water and solutes in the brains of mammals. In: H.M. Pappius and W. Feindel (Eds.), Dynamics of Brain Edema, Springer Verlag, Berlin, Heidelberg, New York, 1976, pp. 87-94.
73. J. Fenstermacher, T. Kaye, Drug "diffusion" within the brain, Ann. N.Y. Acad. Sci. 531 (1988) 29-39.
74. P.F. Morrison, R.L. Dedrick, Transport of cisplatin in rat brain following microinfusion: an analysis, J. Pharm. Sci. 75 (1986) 120-128.
75. C. Nicholson, Interaction between diffusion and Michaelis-Menten uptake of dopamine after ionophoresis in striatum, Biophys. J. 68 (1995) 1699-1715.
76. R.K. Jain, Transport of molecules in the tumor interstitium: a review, Cancer Res. 47 (1987) 3039-3051.
77. L. Fung, M. Shin, B. Tyler, H. Brem, W.M. Saltzman, Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain, Pharm. Res. 13 (1996) 671-682.
78. J.F. Strasser, L.K. Fung, S. Eller, S.A. Grossman, W.M. Saltzman, Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and tracers in the rabbit brain following interstitial delivery by biodegradable polymer implants, J. Pharmacol. Exp. Ther. 275 (1995) 1647-1655.
79. W.M. Saltzman, M.L. Radomsky, Drugs released from polymers: diffusion and elimination in brain tissue, Chem. Eng. Sci. 46 (1991) 2429-2444.
80. L.K. Fung, M. Ewend, A. Sills, S.E.R. Thompson, M. Colvin, H. Brem, W.M. Saltzman, Interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide and taxol from a biodegradable polymer in the monkey brain, 1996. In preparation.
81. W.B. Dang, O.M. Colvin, H. Brem, W.M. Saltzman, Covalent coupling of methotrexate to dextran enhances the penetration of cytotoxicity into a tissue-like matrix, Cancer Res. 54 (1994) 1729-1735.
82. V.G. Witte, B. Kremer, D. Henne-Bruns, A. Jordan, E. Bicheler, Chemoembolisation beim primaren., Leberzellkarzinom. Fortschr. Rontgenstr. 154 (1991) 634-637.
83. G. Falkson, A. Cnaan, I.W. Simson, Y. Dayal, H. Falkson, T.J. Smith, D.G. Haller, A randomized phase II study of activicin and 4-deoxydoxorubicin in patients with hepatocellular carcinoma in an eastern cooperative oncology group study, American Journal of Clinical Oncology 13 (1990) 510-515.
84. G. Falkson, J.M. MacIntyre, C.G. Moertel, L.A. Johnson, R.C. Scherman, Primary liver cancer. An eastern co-operative group trial, Cancer 54 (1984) 970-977.
85. E.C. Lai, T.K. Choi, C.H. Cheng, F.P. Mok, S.T. Fan, E.S. Tan, J. Wong, Doxorubicin for unresectable hepatocellular carcinoma, Cancer 66(8) (1990) 1685-1687.
86. J.L. Raoul, D. Heresbach, J.F. Bretague, D. Bentue Ferrer, R. Duvauferrier, P. Bourguet, M. Messner, M. Gosselin, Chemoembolization of hepatocellular carcinomas, Cancer 70 (1991) 585-590.
87. G. Roos, P. Christensson, I.A. El Hag, B. Jakobsson, H. Teder, U. Stenram, Degradable starch microspheres in cytostatic treatment of a liver carcinoma; experimental studies in rats with 5-fluorouracil, tauromustine, carmustine, doxorubicin and RSU-1069, Anticancer Res. 13 (1993) 635-642.
88. S. Kyotani, Y. Nishioka, M. Okamura, T. Tanaka, M. Miyazaki, S. Ohnishi, Y. Yamamoto, K. Ito, T. Ogiiso, S. Tanada, M. Terao, A study of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma: antitumor effect of cis-diaminedichloroplatinum(II) albumin microspheres, containing chitin and treated with chitosan on rabbits with VX2 hepatic tumors, Chemical & Pharmaceutical Bulletin 40(10) (1992) 2814-2816.
89. Y. Horiguchi, M. Itoh, H. Takagawa, H. Imai, A. Kamei, B. Sekoguchi, Y. Nagamura, Assessment of chemoembolization therapy for primary liver cancer using a stabilized adriamycin-lipiodol suspension, Cancer Chemother. Pharmacol. 31(Suppl. I) (1992) S60-S64.
90. P.J. Johnson, N. Dobbs, C. Kalayci, M.C. Aldous, P. Harper, E.M. Metivier, R. Williams, Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters, Br. J. Cancer 65 (1992) 751-755.
91. H. Teder, C.J. Johansson, The effect of different dosages of degradable starch microspheres (Spherex) on the distribution of doxorubicin regionally administered to the rat, Anticancer Res. 13 (1993) 2161-2164.
92. J.P. Codde, M.A. Burton, D.K. Kelleher, S.A. Archer, B.N. Gray, Reduced toxicity in adriamycin by incorporating into ion exchange microspheres: a therapeutic study using a rat liver tumor model, Anticancer Res. 10 (1990) 1715-1718.
93. C. Jones, M.A. Burton, B.N. Gray, Enhanced in vivo activity of adriamycin incorporated into controlled release microspheres, Br. J. Cancer 59 (1989) 743-745.
94. K.R. Aigner, S. Gailhofer, Regional chemotherapy for non-resectable, localized metastasized pancreatic cancer - four studies including 164 cases. Reg. Cancer Treat. (Suppl. 1) (1993) 2.
95. R.P. de Dycker, J. Timmermann, Combined intra-arterial hepatic infusion of degradable starch microspheres and cytostatics in the treatment of breast cancer liver metastases, Reg. Cancer Treat. 3 (1991) 302-304.
96. P. Michel, J. Nizel, J. Lardinois, F. Bastin, T. Cleve, Regional chemotherapy and breast conservation. Reg. Cancer Treat. (Suppl. 1) (1993) 39.
97. Gutowska, Thermoreversible polymer gels for chemo-embolization therapy of hepatocellular carcinoma. Ann. Biomed. Eng. 24 (1996) S-21.
98. W.M. Saltzman, Growth factor delivery in tissue engineering, Materials Research Society Bulletin 21 (1996) 62-65.
99. P.T. Golumbek, R. Azhari, E.M. Jaffe, H.I. Levitsky, A. Lazenby, K. Leong, D.M. Pardoll, Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design, Cancer Res. 53 (1993) 5841-5844.
100. Y. Tabata, K. Uho, S. Muramatsu, Y. Ikada, In vivo effects of recombinant interferon alpha A/D incorporated in gelatin microspheres on murine tumor cell growth, Jpn. J. Cancer Res. 80 (1989) 387-393.
101. P.C. Phillips, C. Levow, M. Catterall, O.M. Colvin, I. Pastan, H. Brem, Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice, Cancer Res. 54 (1994) 1008-1015.
102. Z. Zhao, E.M. Jaffe, M.C. Thomas, D.M. Pardoll, K.W. Leong, GM-CSF microspheres in cancer immunotherapy -a mechanistic study of the vaccine site, Proceedings of International Symsposium on Controlled Release of Bioactive Materials 23 (1996) 91-92.
103. A. Freese, B. Sabel, W. Saltzman, M. During, R. Langer, Controlled release of dopamine from a polymeric brain implant: in vitro characterization, Exp. Neurol. 103 (1989) 234-238.
104. M.J. During, B.A. Sabel, A. Freese, W.M. Saltzman, A. Deutz, R.H. Roth, R. Langer, Controlled release of dopamine from a polymeric brain implant: in vivo characterization, Ann. Neurol. 25 (1989) 351-356.
105. S. Salehi-Had, W.M. Saltzman, Controlled intracranial delivery of antibodies in the rat, in: J. Cleland and R. Langer (Eds.), Protein Formulations and Delivery, ACS Symposium Series: Washington, D.C., 1994, pp. 278-291.
106. C.S. Reinhard, M.L. Radomsky, W.M. Saltzman, J. Hilton, H. Brem, Polymeric controlled release of dexamethasone in normal rat brain, J. Control. Release 16 (1990) 331-340.
107. H. Brem, A. Domb, D. Lenartz, C. Dureza, A. Olivi, J.I. Epstein, Brain biocompatibility of a biodegradable controlled release polymer consisting of anhydride copolymer of fatty acid dimer and sebacic acid, J. Control. Release 19 (1992) 325-330.
108. K.G. Buahin, K.D. Judy, C. Hartke, A.J. Domb, M. Maniar, O.M. Colvin, H. Brem, Controlled release of 4-hydroperoxycyclophosphamide from the fatty acid dimer-sebacic acid copolymer, Polymers Adv. Technol. 3 (1992) 311-316.
109. T.R. Tice, D.W. Mason, R.M. Gilley, Clinical use and future of parenteral microsphere delivery systems, in: L.F. Precott, and Nimmo, W.S. (Eds.), Novel Drug Delivery and its Therapeutic Application, Wiley, New York, 1989, p. 223.
110. W. Bechtel, K.C. Wright, S. Wallace, B. Mosier, D. Mosier, S. Mir, S. Kuo, An experimental evaluation of microcapsules for arterial chemoembolization, Radiology 161 (1986) 601-604.
111. H. Okada, T. Heya, Y. Ogawa, T. Shimamoto, One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats, J. Pharmacol. Exp. Ther. 244 (1988) 744-750.
112. V.J. Csernus, B. Szende, A.V. Schally, Release of peptides from sustained delivery systems (microcapsules and microparticles) in vitro, International Journal of Peptide Protein Research 35 (1990) 557-565.
113. P.K. Gupta, C.T. Hung, F.C. Lam, Application of regression analysis in the evaluation of tumor response following the administration of adriamycin either as a solution or via albumin microspheres to the rat, J. Pharm. Sci. 79(7) (1990) 634-637.
114. H. Toguchi, Pharmaceutical manipulation of leuprorelin acetate to improve clinical performance, J. Int. Med. Res. 18(Suppl. 1) (1990) 35-41.
115. N. Chiannilkulchai, N. Ammoury, B. Caillou, J.P. Devissaguet, P. Couvreur, Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice, Cancer Chemother. Pharmacol. 26 (1991) 122-126.
116. M.A. Burton, Y. Chen, H. Atkinson, J.P. Codde, S.K. Jones, B.N. Gray, In vitro and in vivo responses of doxorubicin ion exchange microspheres to hyperthermia, Int. J. Hyperthermia 8 (1992) 485-494.
117. R. Verrijk, I.J. Smolders, N. Bosnie, A.C. Begg, Reduction of systemic exposure and toxicity of cisplatin by encapsulation in poly-lactide-co-glycolide, Cancer Res. 52 (1992) 6653-6656.
118. J.P. Codde, A.J. Lumsden, S. Napoli, M.A. Burton, B.N. Gray, A comparative study of the anticancer efficacy of doxorubicin carrying microspheres and liposomes using a rat liver tumour model, Anticancer Res. 13 (1993) 539-543.
119. E.E. Hassen, J.M. Gallo, Targeting anticancer drugs to the brain. I: Enhanced brain delivery of oxantrazone following administration in magnetic cationic microspheres, J. Drug Targeting 1 (1993) 7-14.
120. P. Menei, V. Daniel, C. Montero-Menei, M. Brouillard, A. Pouplard-Barthelaix, M. Benoit, Biodegradation and brain tissue reaction to poly(DL-lactide-co-glycolide) microspheres., Biomaterials 14 (1993) 470-478.
121. G. Barratt, F. Puisieux, W.P. Yu, C. Foucher, H. Fessi, J.P. Devissaguet, Anti-metastatic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules, Int. J. Immunopharmacol. 16 (1994) 457-461.
122. J. Novotny, K. Zinek, Application of epirubicin containing albumin microspheres in the experimental therapy of breast cancer, Neoplasma 41 (1994) 201-204.
123. H.R. Bhagat, R.G. Hollenbeck, P.G. Pande, S. Bogdansky, C.D. Fait, M. Rock, Preparation and evaluation of methotrexate-loaded biodegradable polyanhydride microspheres, Drug Dev. Ind. Pharm. 20 (1994) 1725-1737.
124. D. Devineni, A. Klein-Szanto, J.M. Gallo, Tissue distribution of methotrexate following administration as a solution and a magnetic microsphere conjugate in rats bearing brain tumors, J. Neuro-Oncol. 24 (1995) 143-152.
125. J. Yang, X.C. Ma, Z.J. Zon, S.L. Wei, Experimental maxillofacial arterial chemoembolization with encased-cisplatin ethylcellulose microspheres, Am. J. Neuroradiol. 16 (1995) 1037-1041.
126. I.S. Wollner, S.C. Walker-Andrews, J.E. Smith, W.D. Ensminger, Phase II study on hepatic arterial degradable starch microspheres and mitomycin, Cancer Drug Delivery 3(4) (1986) 279-284.
127. M. Kitamura, K. Arai, K. Miyashita, G. Kosaki, Arterial infusion chemotherapy in patients with gastric cancer in liver metastasis and long-term survival after treatment [Japanese], Japanese Journal of Cancer & Chemotherapy 16(8 Pt 2) (1989) 2936-2939.
128. A.K. Thom, E.R. Sigurdson, M. Bitar, J.M. Daly, Regional hepatic arterial infusion of degradable starch microspheres increases fluorodeoxyuridine (FUdR) tumor uptake, Surgery 105(3) (1989) 383-392.
129. G.A. Dijkman, P.F. del Moral, J.W. Plasman, J.J. Kums, K.P. Delaere, F.M. Debruyne, F.J. Hutchinson, B.J. Furr, A new extra long acting depot preparation of the LHRH analogue Zoladex. First endocrinological and pharmacokinetic data in patients with advanced prostate cancer, Journal of Steroid Biochemistry & Molecular Biology 37(6) (1990) 933-936.
130. J.A. Goldberg, N.S. Willmott, J.H. Anderson, G. McCurrach, R.G. Bessent, J.H. McKillop, C.S. McArdle, The biodegradation of albumin microspheres used for regional chemotherapy in patients with colorectal liver metastasis, Nuclear Medicine Communications 12(1) (1991) 57-63.
131. 131I and chemotherapeutic agent gelatin microspheres report of 9 cases [Chinese], Journal of West China University of Medical Sciences 23(4) (1992) 420-423.
132. D. Civalleri, J.C. Pector, L. Hakansson, J.P. Arnaud, N. Duez, M. Buyse, Treatment of patients with irresectable liver metastates from colorectal cancer by chemo-occlusion with degradable starch microspheres, British Journal of Surgery 81(9) (1994) 1338-1341.
133. J.C. Doughty, J.H. Anderson, N. Willmott, C.S. Asardle, Intra-arterial administration of adriamycin-loaded albumin microspheres for locally advanced breast cancer, Postgraduate Medical Journal 71(831) (1994) 47-49.
134. B. Rama, T. Mandel, J. Jansen, E. Dingeldein, H.D. Mennel, The intraneoplastic chemotherapy in a rat brain tumor model utilizing methotrexatepolymethylacrylate-pellets, Acta Neurochirurgica 87 (1987) 70-75.
135. A.J. Domb, M. Rock, C. Perkin, G. Yipchuck, B. Broxup, J.G. Villemure, Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain, Biomaterials 16(14) (1995) 1069-1072.
136. K. Imai, H. Yamanaka, H. Yuasa, M. Yoshida, M. Asano, I. Kaetu, I. Yamazaki, K. Suzuki, The sustained release of LH X RH agonist-polymer composite in patients with prostatic cancer, Prostate 8(4) (1986) 325-332.
137. F. Hanyu, M. Nakamura, T. Takasaki, Y. Kasai, T. Sato, H. Sato, Y. Sukurai, A. Yamada, T. Okawa, T. Salabe, Clinical study of controlled-release preparation of mitomycin C in the treatment of inoperable cancer patients [Japanese], Japanese Journal of Cancer & Chemotherapy 15(11) (1988) 3087-3093.
138. W.J. Zeller, S. Bauer, T. Remmele, B. Wowra, V. Sturm, H. Stricker, Interstitial chemotherapy of experimental gliomas, Cancer Treatment Reviews 17 (1990) 183-189.
139. R. Kuroda, F. Akai, H. Iwasaki, J. Nakatani, T. Uchiyama, M. Ioku, I. Kaetsu, Interstitial chemotherapy with biodegradable ACNU pellet for glioblastoma, Sterotactic and Functional Neurosurgery 63(1-4) (1994) 154-159.
140. M. Asano, H. Fukuzaki, M. Yoshida, M. Kumakura, T. Mashimo, H. Yuasa, K. Imai, K. Yamanaka, In vivo characteristics of low molecular weight copoly(D,L-lactic acid) formulations with controlled release of LH-RH agonist, Biomaterials 10(8) (1989) 569-573.
141. H. Fukuzaki, M. Yoshida, M. Asano, M. Kumakura, T. Mashimo, H. Yuasa, K. Imai, H. Yamasaka, In vivo characteristics of low molecular weight copolymers composed of L-lactic acid and various DL-hydroxy acids as biodegradable carriers for drug delivery systems, Biomaterials 11 (1990) 441-446.
142. A.J. Domb, M. Rock, J. Schwartz, C. Perkin, G. Yipchuk, B. Broxup, J.G. Villemure, Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain, Biomaterials 15(9) (1994) 681-688.
143. J. Heller, Development of poly(ortho esters): a historical overview, Journal of Controlled Release 11(9) (1990) 659-665.
144. R.J. Tamargo, A.K. Sills Jr., C.S. Reinhard, M.L. Pinn, D.M. Long, H. Brem, Interstitial delivery of dexamethasone in the brain for the reduction of peritumoral edema, Journal of Neurosurgery 74 (1991) 956-961.
145. S. Miura, Y. Mii, Y. Miyauchi, H. Ohgushi, T. Morishita, K. Hohnoki, M. Aoki, S. Tamai, Y. Konishi, Efficacy of slow-releasing anticancer drug delivery systems on transplantable osteosarcomas in rats, Japanese Journal of Clinical Oncology 25(3) (1995) 61-71.
146. G. Barratt, F. Puisieux, W.P. Yu, C. Foucher, H. Fessi, J.P. Devissaguet, Anti-metastatic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules, International Journal of Immunopharmacology 16(5-6) (1994) 457-461.
147. O. Kubo, H. Himuro, N. Inoue, Y. Tajika, T. Tajika, T. Tohyama, M. Sakairi, M. Yoshida, I. Kaetsu, K. Kitamura, Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites [Japanese], No Shinkei Geka Neurological Surgery 14(10) (1986) 1189-1195.